References
- Borrmann L R, Leopold I H. The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol 1988; 106: 227–228
- Reidy J J, Hobden J A, Hill J M, Forman K, O'Callaghan R J. The efficacy of topical Ciprofloxacin and Norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 1991; 10((1))25–28
- Borrman L, Tang-Liu D, Kann J, Nista J, Lin E T, Frank F. Ofloxacin in human serum, urine, and tear film after topical application. Cornea 1992; 11((3))226–230
- Osato M S, Jensen H G, Trousdale M D, Bosso J, Borrmann L R, Frank J, Akers P. The comparative in vitro activity of Ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol 1989; 108: 380–386
- Mitsui Y, Sakuragi S, Tamura O. Effect of Ofloxacin ophthalmic solution in the treatment of external bacterial infections of the eye. Folia Ophthalmol Jpn 1986; 37: 1115
- Kumada T, Neu H C. In vitro activity of Ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents. J Antimicrob Chemother 1985; 16: 563